Back to Search Start Over

The effect of quercetin and imperatorin on programmed cell death induction in T98G cells in vitro

Authors :
Ewa Langner
Antoni Gawron
Wojciech Rzeski
Dorota Bądziul
Joanna Jakubowicz-Gil
Kazimierz Głowniak
Source :
Pharmacological reports : PR. 66(2)
Publication Year :
2012

Abstract

Background High expression of HSP27 and HSP72 in glioma cells has been closely associated with chemoresistance and decreased sensitivity to programmed cell death induction. Therefore, it is important to devise therapies that effectively target invasive cancer cells by inducing cell death. The aim of our study was to assess the effect of quercetin and imperatorin applied separately and in combinations on the apoptosis and autophagy induction in human T98G cells cultured in vitro . Methods Cell death induction was analyzed by the staining method. The Western blotting technique and fluorimetric measurements of activity were used to assess the expression of marker proteins of apoptosis and autophagy. The specific siRNA transfected method was used for blocking of the expression of HSP27 and HSP72 genes. Results The experiments revealed the highest percentage of apoptotic cells after using a 50 μM concentration of both compounds. Simultaneous quercetin and imperatorin administration induced apoptosis more effectively than incubation with single drugs. These results were accompanied with decreased HSP27 and HSP72 expression, and a high level of caspase-3 and capsae-9 activity. Autophagy was not observed. Additional experiments were performed on a cell line with blocked Hsp27 and Hsp72 expression and significant increase the sensitivity to apoptosis induction upon quercetin and imperatorin treatment was noticed. Conclusions The present study indicates that quercetin and imperatorin are potent apoptosis inducers, especially when they act synergistically, which may be a promising combination useful in glioma therapy. Our results also demonstrated that blocking the HSP27 and HSP72 gene expression might serve as a therapeutic target for the human brain cancer.

Details

ISSN :
22995684
Volume :
66
Issue :
2
Database :
OpenAIRE
Journal :
Pharmacological reports : PR
Accession number :
edsair.doi.dedup.....f749062e0d70525a98e2473da5750593